← FDA Drug Approvals (Drugs@FDA)
AIRSUPRA
NDA · New Drug Application · Sponsor: ASTRAZENECA · Approved 2023-01-10
Drug application
- FDA Application #
NDA214070- Application type
- New Drug Application
- Brand name
- AIRSUPRA
- Generic name
- ALBUTEROL SULFATE AND BUDESONIDE
- Active ingredients
- ALBUTEROL SULFATE; BUDESONIDE
- Dosage form
- AEROSOL, METERED
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- ASTRAZENECA
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- First approval
- 2023-01-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown